REQUEST A DEMO
Total
USD $0.00
Search more companies

Avalon Pharmaceutical Ecuador Avalonphar S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Avalon Pharmaceutical Ecuador Avalonphar S.A. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Avalon Pharmaceutical Ecuador Avalonphar S.A. is a company in Ecuador, with a head office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on January 26, 2015. 1 (2024) employees currently work for Avalon Pharmaceutical Ecuador Avalonphar S.A.. There was a net sales revenue drop of 100% reported in Avalon Pharmaceutical Ecuador Avalonphar S.A.’s latest financial highlights for 2025. Over the same period, its total assets grew by 173.87%.

Headquarters
Calle El Batan, N-3966
Quito; Pichincha;

Contact Details: Purchase the Avalon Pharmaceutical Ecuador Avalonphar S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Avalon Pharmaceutical Ecuador Avalonphar S.A. report to view the information.
Registered Capital:
Purchase the Avalon Pharmaceutical Ecuador Avalonphar S.A. report to view the information.
Financial Auditors:
Purchase the Avalon Pharmaceutical Ecuador Avalonphar S.A. report to view the information.
Incorporation Date:
January 26, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.99%
Purchase this report to view the information.
0.01%
Company Performance
Financial values in the chart are available after Avalon Pharmaceutical Ecuador Avalonphar S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-100%
Total Operating Revenue
-100%
Operating Profit
-46.04%
EBITDA
98.59%
Net Profit/Loss for the Period
-46.04%
Total Assets
173.87%
Total Equity
-4.05%
Return on Equity (ROE)
1.69%
Quick Ratio
9.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?